IL250392B - A method for determining pik3ca mutational status in a sample - Google Patents

A method for determining pik3ca mutational status in a sample

Info

Publication number
IL250392B
IL250392B IL250392A IL25039217A IL250392B IL 250392 B IL250392 B IL 250392B IL 250392 A IL250392 A IL 250392A IL 25039217 A IL25039217 A IL 25039217A IL 250392 B IL250392 B IL 250392B
Authority
IL
Israel
Prior art keywords
sample
determining
mutational status
pik3ca mutational
pik3ca
Prior art date
Application number
IL250392A
Other languages
English (en)
Hebrew (he)
Other versions
IL250392A0 (en
Original Assignee
Pharmassist Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmassist Ltd filed Critical Pharmassist Ltd
Publication of IL250392A0 publication Critical patent/IL250392A0/en
Publication of IL250392B publication Critical patent/IL250392B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10Modifications characterised by
    • C12Q2525/186Modifications characterised by incorporating a non-extendable or blocking moiety
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00Reactions demanding special reaction conditions
    • C12Q2527/107Temperature of melting, i.e. Tm
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
IL250392A 2014-08-07 2017-02-01 A method for determining pik3ca mutational status in a sample IL250392B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462034231P 2014-08-07 2014-08-07
PCT/GR2015/000036 WO2016020710A1 (en) 2014-08-07 2015-07-28 Method of determining pik3ca mutational status in a sample

Publications (2)

Publication Number Publication Date
IL250392A0 IL250392A0 (en) 2017-03-30
IL250392B true IL250392B (en) 2020-03-31

Family

ID=53938365

Family Applications (1)

Application Number Title Priority Date Filing Date
IL250392A IL250392B (en) 2014-08-07 2017-02-01 A method for determining pik3ca mutational status in a sample

Country Status (18)

Country Link
US (1) US11279979B2 (OSRAM)
EP (1) EP3198026B1 (OSRAM)
JP (1) JP6770957B2 (OSRAM)
CN (1) CN106715723B (OSRAM)
CA (1) CA2957396C (OSRAM)
CY (1) CY1122647T1 (OSRAM)
DK (1) DK3198026T3 (OSRAM)
ES (1) ES2764423T3 (OSRAM)
HR (1) HRP20192353T1 (OSRAM)
HU (1) HUE047958T2 (OSRAM)
IL (1) IL250392B (OSRAM)
LT (1) LT3198026T (OSRAM)
PL (1) PL3198026T3 (OSRAM)
PT (1) PT3198026T (OSRAM)
RS (1) RS59710B1 (OSRAM)
SI (1) SI3198026T1 (OSRAM)
SM (1) SMT202000005T1 (OSRAM)
WO (1) WO2016020710A1 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102017898B1 (ko) 2010-05-14 2019-09-04 더 제너럴 하스피톨 코포레이션 종양 특이적 신생항원을 확인하는 조성물 및 방법
WO2015039024A1 (en) 2013-09-16 2015-03-19 Oregon Health & Science University Bioabsorbable clips and applicator for tissue closure
WO2015077717A1 (en) 2013-11-25 2015-05-28 The Broad Institute Inc. Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
WO2015085147A1 (en) 2013-12-05 2015-06-11 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
EP3082853A2 (en) 2013-12-20 2016-10-26 The Broad Institute, Inc. Combination therapy with neoantigen vaccine
ES2864278T3 (es) 2014-11-03 2021-10-13 Univ Oregon Health & Science Clips y aplicador para cierre de tejidos
ES3049406T3 (en) 2014-12-19 2025-12-16 Broad Inst Inc Methods for profiling the t-cell-receptor repertoire
EP3234193B1 (en) 2014-12-19 2020-07-15 Massachusetts Institute of Technology Molecular biomarkers for cancer immunotherapy
CN108025048B (zh) 2015-05-20 2022-10-25 博德研究所 共有的新抗原
EP3358020B1 (en) * 2017-01-05 2021-05-19 Biodesix, Inc. Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood
US11549149B2 (en) 2017-01-24 2023-01-10 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
EP3606550A2 (en) 2017-04-03 2020-02-12 Neon Therapeutics, Inc. Protein antigens and uses thereof
CN107287309A (zh) * 2017-07-06 2017-10-24 罗保君 一种血液循环肿瘤dna点突变检测方法
EP3660168A4 (en) * 2017-07-26 2021-04-21 Sekisui Medical Co., Ltd. METHOD OF DETECTING MUTUAL GENES
CN109306374A (zh) * 2017-09-08 2019-02-05 广州健天基因技术有限公司 用于检测人类pik3ca基因e545k突变的引物、检测方法及试剂盒
CN109295175A (zh) * 2017-09-08 2019-02-01 广州健天基因技术有限公司 用于检测人胃肠道间质瘤c-kit基因v559a突变的引物、检测方法及试剂盒
JP7306618B2 (ja) * 2017-09-26 2023-07-11 東ソー株式会社 がんの転移形成能に関与する因子および前記因子を用いたがん患者の予後予測方法
US11793867B2 (en) 2017-12-18 2023-10-24 Biontech Us Inc. Neoantigens and uses thereof
CN107937490A (zh) * 2018-01-15 2018-04-20 福建农林大学 一种非对称pcr的试纸条检测植物病原菌的方法及试剂盒
JP2021513342A (ja) * 2018-02-12 2021-05-27 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 腫瘍の遺伝的不均一性を評価することによって治療法に対する応答を予測する方法
US12246067B2 (en) 2018-06-19 2025-03-11 Biontech Us Inc. Neoantigens and uses thereof
CN109666747A (zh) * 2019-02-20 2019-04-23 天津脉络医学检验有限公司 一种引物探针组合物及其应用
US11812966B2 (en) 2020-04-24 2023-11-14 NeuraMedica Inc. Clips, appliers, and cartridges
CN113930500B (zh) * 2020-07-13 2024-11-19 铭炽生物科技(上海)有限公司 人pik3ca基因突变的数字pcr检测方法及应用
CN112951325B (zh) * 2021-02-18 2023-04-21 北京吉因加医学检验实验室有限公司 一种用于癌症检测的探针组合的设计方法及其应用
CN113063835B (zh) * 2021-03-19 2022-08-02 中山大学 一种基于元素标记-电感耦合等离子体质谱检测策略的cfDNA分析方法及其应用
WO2023025218A1 (zh) * 2021-08-25 2023-03-02 南京金斯瑞生物科技有限公司 一种用于检测单碱基突变的引物组和基因芯片方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2437590T3 (es) * 2004-03-02 2014-01-13 The Johns-Hopkins University Mutaciones del gen de PIK3CA en cánceres humanos
SG10201506658TA (en) * 2007-02-26 2015-09-29 Wayne John Cancer Inst Utility of b-raf dna mutation in diagnosis and treatment of cancer
US8071338B2 (en) * 2007-08-08 2011-12-06 Roche Molecular Systems, Inc. Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5′-3′ nuclease activity
GB2453173A (en) 2007-09-28 2009-04-01 Dxs Ltd Polynucleotide primers
US20100041048A1 (en) * 2008-07-31 2010-02-18 The Johns Hopkins University Circulating Mutant DNA to Assess Tumor Dynamics
CN101445832B (zh) * 2008-12-23 2011-09-14 广州益善生物技术有限公司 Pik3ca基因突变的检测探针、液相芯片及其检测方法
CN102234685B (zh) * 2010-04-23 2014-08-27 益善生物技术股份有限公司 一种pik3ca基因突变检测液相芯片
EP2646576B1 (en) 2010-12-03 2015-10-28 Brandeis University Methods and kits for detecting nucleic acid mutants in wild-type populations
CN102533958A (zh) 2010-12-28 2012-07-04 苏州科贝生物技术有限公司 一种检测人pik3ca基因突变的方法和试剂盒
WO2012095378A1 (en) * 2011-01-11 2012-07-19 Roche Diagnostics Gmbh High resolution melting analysis as a prescreening tool
WO2012131092A2 (en) * 2011-03-31 2012-10-04 Signature Diagnostics Ag Method and kits for the prediction of response/nonresponse to the treatment with an anti-egfr antibody in patients with colorectal cancer of all uicc stages
CN103635593B (zh) * 2011-05-04 2018-03-20 生物概念股份有限公司 用于检测核酸序列变体的方法
AU2012296385A1 (en) 2011-08-18 2014-02-20 Nestec S.A. Compositions and methods for detecting allelic variants
JP2013081450A (ja) * 2011-09-27 2013-05-09 Arkray Inc 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用試薬キット
US11261494B2 (en) * 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
EP2711432A1 (en) * 2012-09-21 2014-03-26 Genomica S.A.U. Method for detection of BRAF and PI3K mutations
CN105378160B (zh) * 2013-08-12 2018-04-17 伯乐生命医学产品有限公司 具有碱基配对的寡聚体的扩增报告子

Also Published As

Publication number Publication date
HRP20192353T1 (hr) 2020-03-20
PL3198026T3 (pl) 2020-05-18
EP3198026B1 (en) 2019-10-09
US11279979B2 (en) 2022-03-22
JP2017523810A (ja) 2017-08-24
RS59710B1 (sr) 2020-01-31
ES2764423T3 (es) 2020-06-03
HUE047958T2 (hu) 2020-05-28
CN106715723B (zh) 2021-03-30
DK3198026T3 (da) 2020-01-20
IL250392A0 (en) 2017-03-30
EP3198026A1 (en) 2017-08-02
CA2957396C (en) 2021-03-09
SI3198026T1 (sl) 2020-02-28
CA2957396A1 (en) 2016-02-11
SMT202000005T1 (it) 2020-03-13
PT3198026T (pt) 2020-01-16
JP6770957B2 (ja) 2020-10-21
CN106715723A (zh) 2017-05-24
LT3198026T (lt) 2020-01-27
CY1122647T1 (el) 2021-03-12
WO2016020710A1 (en) 2016-02-11
US20170233821A1 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
IL250392B (en) A method for determining pik3ca mutational status in a sample
SG11201703656PA (en) Methods for transduction and cell processing
GB201403096D0 (en) Sample preparation method
GB201417162D0 (en) Inspection appartus
GB201402318D0 (en) Method for materials analysis
GB201708360D0 (en) Methods for determining health risks
SG11201606193RA (en) Biomolecule analysis kit and biomolecule analysis method
GB201407770D0 (en) Sensing methods and apparatus
GB201408100D0 (en) Detection method
SG11201701014VA (en) Concentration measuring method
IL230567A0 (en) Method and system for endophyll implantation in the eye
IL246889A0 (en) A method for measuring engagement
GB201409152D0 (en) Method and apparatus for automated manufacture
GB201415367D0 (en) Methods for detecting abnormalities in haemoglobin
ZA201607571B (en) Compositions and methods for detecting huanglongbing
GB201607628D0 (en) Method of detecting a mutational signature in a sample
GB201514411D0 (en) Kit and method
GB201410283D0 (en) Sensing methods and apparatus
SG10201502676TA (en) Unauthorized-communication detecting apparatus and program
GB201411571D0 (en) Radiolabelling method
GB201416459D0 (en) Detection method
IL247996B (en) A method for detecting changes in proteins
HUE039330T2 (hu) Eljárás dohányrudak feldolgozására
GB201419330D0 (en) Detection method
GB201415338D0 (en) Cell processing method

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed